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Introduction: Hypertrophic cardiomyopathy (HCM) represents a generalized myopathic process affect-
ing both ventricular and atrial myocardium. Reduced left atrial (LA) function was demonstrated in HCM
by different methods. Three-dimensional (3D) speckle tracking echocardiography (STE) has just been
introduced for the evaluation of LA. This study was designed to compare 3DSTE-derived LA volumetric
and strain parameters in HCM with healthy controls. Methods: The study comprised 23 consecutive
HCM patients (mean age: 48.5  15.1 years, 14 men). Their results were compared to 23 age- and
gender-matched healthy controls. Complete two-dimensional Doppler echocardiography and 3DSTE
have been performed in all cases. Results: Calculated LA maximum (66.4  20.4 mL vs. 36.0
 6.1 mL, P < 0.0001) and minimum (39.2  19.1 vs. 16.0  4.6 mL, P < 0.0001) volumes and LA
volume before atrial contraction (53.6  19.9 vs. 24.0  6.2 mL, P < 0.0001) were signiﬁcantly
increased in HCM patients. Atrial stroke volumes respecting cardiac cycles proved to be increased, while
emptying fractions were decreased in subjects with HCM. Mean global radial (12.2  6.7% vs.
19.6  11.7, P < 0.05), longitudinal (26.5  16.5% vs. 29.8  12.1%, P < 0.05) and 3D strain
(6.1  4.4% vs. 12.5  10.2%, P < 0.05) proved to be signiﬁcantly reduced in HCM patients as
compared with matched controls. Conclusions: Three-dimensional speckle tracking echocardiography
allows detailed evaluation of LA (dys) function in HCM by volumetric and strain measurements. (Echo-
cardiography 2014;31:1245–1252)
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Hypertrophic cardiomyopathy (HCM) is a com-
plex, relatively common genetic cardiac disease
that is heterogeneous with respect to gene muta-
tions, clinical symptoms, prognosis, and treatment
strategies.1 HCM represents a generalized myo-
pathic process affecting both ventricular and atrial
myocardium.2 Most of the patients are in steady
condition, although HCM is known as one of the
most common cause of sudden death in juvenile
patients.1 HCM is characterized by excessive
asymmetric left ventricular (LV) hypertrophy
involving primarily the interventricular septum.1 It
is known that diastolic LV dysfunction is more
common in HCM than systolic dysfunction. Due
to reduced ventricular compliance and impaired
relaxation, elevated left atrial (LA) and pulmonary
vascular pressures are known complications in
HCM.3 Due to sensitivity of thin-walled LA to vol-
ume and pressure changes, increased LV load
pressure could lead to LA dilation which is known
to be associated with increased morbidity and
mortality in HCM.4 Enlarged LA volume was found
to be associated with impaired functional NYHA
class and shows inverse correlation with treadmill
exercise capacity in HCM.5 P-wave duration com-
bined with LA antero-posterior diameter and myo-
cardial deformation indices resulted in a higher
power for discriminating HCM patients with
paroxysmal atrial ﬁbrillation.6 All these studies
should draw our attention to the importance of
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accurate evaluation of LA volumes and function
respecting cardiac cycle in HCM.6 Changes could
be demonstrated in all three components of LA
function in HCM: in the phase of reservoir compo-
nent or expansion during systole, in conduit
phase during diastole and in active contractile
phase during late diastole.7
Several clinical noninvasive tools have been
demonstrated to be useful for assessment of LA
function in HCM. Three-dimensional (3D) speckle
tracking echocardiography (STE) seems to be a
promising tool for accurate evaluation of global
and regional cardiac function.8 3DSTE has just
been introduced for the evaluation of LA.9–12 This
study was designed to measure and compare
3DSTE-derived LA volumetric and strain parame-
ters in HCM and healthy matched controls.
Patients and Methods:
Patient Population:
A total of 23 patients with typical features of
HCM were included in this study. The diagnosis
of HCM was conﬁrmed in all patients according
to the guidelines.13 In all cases, hypertrophy was
asymmetrical and had septal localization. HCM
was known for several years in these patients,
and 75% of the cases were genetically analyzed
with genotype/mutation analysis. Their results
were compared to 23 age- and gender-matched
healthy controls. All healthy subjects with known
diseases which could affect the results were
excluded from the control group. Complete two-
dimensional (2D) Doppler echocardiography and
3DSTE have been performed in all HCM cases
and controls. Diabetes mellitus (DM) was deﬁned
in accordance with the American Diabetes Asso-
ciation and World Health Organization criteria.
Hypertension was deﬁned as either a systolic or a
diastolic elevation of the blood pressure (>140/
90 mmHg) or ongoing antihypertensive therapy.
Hypercholesterolemia was deﬁned as a total cho-
lesterol level >5.0 mmol/L or current treatment
with lipid-lowering medications. All subjects have
been included in the MAGYAR-Path Study
(Motion Analysis of the heart and Great vessels
bY three-dimensionAl speckle tRacking echocar-
diography in Pathological cases). This has been
organized at the Cardiology Center of the Uni-
versity of Szeged, Hungary to evaluate usefulness,
diagnostic and prognostic value of 3DSTE-
derived volumetric, strain, rotational etc. parame-
ters in pathological cases (“magyar” means in
Hungarian language “Hungarian”). Informed
consent was obtained from each patient and the
study protocol conformed to the ethical guide-
lines of the 1975 Declaration of Helsinki, as
reﬂected in a priori approval by the institution’s
human research committee.14
Two-Dimensional Echocardiography:
Complete 2D Doppler echocardiographic exam-
inations were performed in all cases. Standard 2D
echocardiographic studies were carried out with
a commercially available Toshiba Artida echocar-
diography equipment (Toshiba Medical Systems,
Tokyo, Japan) with a PST-30SBP (1–5 MHz)
phased array transducer. LV dimensions, volumes
and ejection fraction, and LA dimension were
measured in parasternal long-axis view by Teich-
holz method in all cases. Color Doppler echocar-
diography was used to visually quantify degree of
mitral regurgitation (MR).
3DSTE Volumetric Measurements:
All patients underwent 3D echocardiographic
acquisitions immediately following 2D echocar-
diographic study using a commercially available
PST-25SX matrix-array transducer (Toshiba Medi-
cal Systems) with 3DSTE capability.9–12 Within a
single breath-hold and during a constant RR
interval, 6 wedge-shaped subvolumes were
acquired from an apical window to create full-
volume 3D datasets. The sector width was
decreased as much as possible to improve tem-
poral and spatial resolution of the image to
obtain a full-volume dataset of LA with optimal
border delineation. Chamber quantiﬁcation by
3DSTE was performed ofﬂine using 3D Wall-
Motion Tracking software version 2.5 (Toshiba
Medical Systems). 3D echocardiographic data-
sets were displayed in apical four-chamber
(AP4CH) and two-chamber (AP2CH) views and 3
short-axis views in basal, midatrial, and superior
LA regions, respectively (Fig. 1). In the AP4CH
and AP2CH views, the endocardial border was
traced by setting multiple reference points by the
user starting at base of the LA at mitral valve level
going toward the LA apex and excluding the LA
appendage and pulmonary veins from the LA
cavity (Fig. 1). The epicardial border was
adjusted manually or by setting a default thick-
ness for the myocardium. After detection of the
LA borders at the end-diastolic reference frame
3D wall-motion tracking, which is based on 3D
block-matching algorithm, was automatically
performed by the software. The user could cor-
rect the shape of the LA if needed throughout
the entire cardiac cycle.
The following volumetric calculations have been
performed15:
(1) Maximum volume (Vmax) at end-systole, the
time at which atrial volume was largest just
before mitral valve opening,
(2) Minimum volume (Vmin): at end-diastole, the
time at which atrial volume is at its nadir
before mitral valve closure,
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(3) Volume before atrial contraction (VpreA): the
last frame before mitral valve reopening or at
the time of P-wave on ECG.
From the three volumes several parameters
characterizing each phase of LA function could
be assessed (see Table I).
3DSTE Strain Measurements:
The following strain parameters were routinely
measured by the software in a semiautomatic
fashion from the 3D echocardiographic dataset:
longitudinal strain (LS) in the direction tangential
to the endocardial contour, circumferential strain
(CS) in circumferential direction, and radial strain
(RS) in perpendicular direction to the endocardial
contour. Besides these “unidimensional” parame-
ters, novel strain parameters using 3D wall-
motion tracking were also recorded, such as 3D
strain (3DS) deﬁned as strain in the direction of
wall thickening and area strain (AS) as a ratio of
endocardial area change during the cardiac
cycle.10,11 Examples of time-strain curves gener-
ated by the software are given in Figure 2.
Statistical Analysis:
All data are reported as mean  standard devia-
tion. A value of P < 0.05 was considered to be
statistically signiﬁcant. Independent samples Stu-
dent’s t-test were used to compare continuous
variables and chi-square test to compare categor-
ical ones. MedCalc software was used for statisti-
cal calculations (MedCalc, Mariakerke, Belgium).
Figure 1. Images from three-dimensional full-volume dataset showing left atrium in a patient with hypertrophic cardiomyopa-
thy: A. apical four-chamber view, B. apical two-chamber view, C3. parasternal short-axis view at basal, C5. mid- and C7. superior
left atrial level. The semiautomated left atrial border deﬁnition and three-dimensional “wire” reconstruction of the left atrium
based on three-dimensional speckle tracking echocardiographic analysis are also presented.
TABLE I
The Way to Calculate Left Atrial Stroke Volumes and Emptying Fractions in Each Phase of Left Atrial Motion
Functions Stroke Volumes (mL) Emptying Fractions (%)
Reservoir Total SV = Vmax  Vmin Total EF = Total SV/Vmax
Conduit function Passive SV = Vmax  VpreA Passive EF = Passive SV/Vmax
Active contraction Active SV = VpreA  Vmin Active EF = Active SV/VpreA
EF = emptying fraction; SV = stroke volume; Vmax = maximum left atrial volume; Vmin = minimum left atrial volume; VpreA = left
atrial volume before left atrial contraction.
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Results:
Clinical Characteristics:
Classic cardiovascular risk factors and medica-
tions of HCM patients and controls are presented
in Table II. Eleven of 23 HCM patients had signiﬁ-
cant (>30 mmHg) resting peak LV outﬂow tract
gradient (mean: 69.5  30.1 mmHg), whereas
15 HCM patients had systolic anterior motion of
the anterior leaﬂet of the mitral valve. Other 3
HCM patients had implantable cardiac deﬁbrilla-
tor due to prophylaxis of malignant arrhythmia
and 1 HCM patient had biological prosthetic
valve in aortic position. One HCM patient had
former percutaneous transluminal septal myocar-
dial ablation.
Two-Dimensional Echocardiographic Data:
Standard 2D echocardiographic data are summa-
rized in Table II. Signiﬁcant (≥grade 2) MR could
be detected in 9 HCM patients (39%). LV end-
systolic diameter was signiﬁcantly decreased,
while interventricular septum was signiﬁcantly
increased in HCM patients (Table II).
Three-Dimensional Speckle Tracking
Echocardiographic Data:
Signiﬁcantly increased LA volumes respecting
heart cycle could be detected in HCM patients.
Total and active atrial stroke volumes (TASV and
AASV) were signiﬁcantly increased, whereas total
and passive atrial emptying fractions (TAEF and
PAEF) were signiﬁcantly decreased in patients
with HCM (Table III). Global and mean segmen-
tal strain parameters proved to be reduced in
HCM patients as compared to controls
(Table IV). There were no differences between
HCM patients with versus without hypertension
and/or DM in this patient population in both LA
volumetric and strain functional properties. Cal-
culated LA volumes were signiﬁcantly larger in
HCM patients with MR ≥2 versus cases with MR
<2, only TAEF showed signiﬁcant difference from
calculated parameters. There were no differences
between HCM patients with MR ≥2 versus MR <2
in strain parameters.
Discussion:
To the best of the authors’ knowledge, this is the
ﬁrst study in which increased LA volumes and
total and active LA stroke volumes could be dem-
onstrated in patients with HCM by 3DSTE. More-
over, total and passive LA emptying fractions
proved to be signiﬁcantly decreased. 3DSTE-
derived strain parameters were also reduced in
HCM patients as compared with matched con-
trols. These data could draw our attention to the
fact that 3DSTE enables more detailed evaluation
of LA dysfunction including detection of volu-
metric changes respecting its motion during
heart cycle, even in HCM. Moreover, evaluation
of different strains at the same time seems to be
a quantitative way to demonstrate LA functional
abnormalities.
Several noninvasive imaging methods includ-
ing M-mode and 2D Doppler echocardiogra-
phy,16,17 2DSTE,18 tissue Doppler imaging
(TDI),18 volumetric real time 3D echocardiogra-
phy (RT3DE),9,15 cine computed tomography
A
B
Figure 2. Examples of time-strain curves of 16 left atrial segments in a healthy control subject A. and in a patient with
hypertrophic cardiomyopathy B.
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(CT),19 cardiovascular magnetic resonance
(CMR) 20 etc. have been used for evaluation of
LA dimensions, volumes, and function. Recently,
3DSTE has been introduced, which encompasses
beneﬁts of STE and 3D echocardiography.
3DSTE uses different algorithm from RT3DE
which is based on block matching of the myo-
cardial speckles of the endocardial border during
their frame-to-frame motion.21 Kleijn et al.9 have
demonstrated that 3D echocardiography with
direct volumetric (RT3DE) and speckle tracking
methods (3DSTE) gives comparable and repro-
ducible quantiﬁcation of LV and LA volumes and
function, making changeable application a via-
ble option in daily clinical practice. Over assess-
ment of LA volumetric and functional properties,
3DSTE seems to be reliable method for the
accurate measurement of LV volumes respecting
cardiac cycle.22–24 3DSTE is also able to quantify
regional and global LV myocardial deformation
by strain analysis from a single data aquisi-
tion.25–27 3DSTE is a noninvasive tool for quanti-
ﬁcation of rotational and twist LV mechanics as
well.28–30 Several calculated dyssynchrony
parameters of the LV have been demonstrated
by different authors.31–33 Some speciﬁc case
report suggested its role in the evaluation of LA
appendage34 and quantiﬁcation of right ventric-
ular volumes35 and aortic root rotation36 etc.
However, its clinical utility in the evaluation of
the heart and large vessels is not fully described
in the literature.
Increased volumes and impaired LA myocar-
dial deformation are known features in HCM.37
Moreover, occurrence of myocardial ﬁbrosis in
HCM was found to be associated with LA dys-
function.38 Abnormalities in strain theoretically
could be due to chronically high LA pressures
from diastolic dysfunction, LV outﬂow tract
obstruction or higher grade MR, but intrinsic
abnormalities including ﬁbrosis of the LA wall
should also be considered. However, further
studies are warranted to examine whether rela-
tionship exists between dynamic obstruction and
LA functional parameters detailed above. More-
over, the effect of alcohol septal ablation on
these parameters could be also a subject of
research.
Limitation Section:
The following important limitations should be
taken into consideration:
(1) It is known that current image quality of
3DSTE is worse than that of 2D echocardiog-
raphy due to low temporal and spatial image
resolutions which could theoretically affect
our results.
(2) 3DSTE seems to be feasible method for volu-
metric 9,12 and strain10,11 assessment of the
LA. Despite the fact that several noninvasive
tools (TDI, RT3DE, 2DSTE, CMR, CT, etc.)
could be used to quantify LA volumes and
function,9,15–20 only limited number of stud-
ies are available, in which 3DSTE was com-
pared to these widely used and accepted
methodologies.9,12 Therefore, more compar-
ative studies with other methods are war-
ranted especially focusing on the limitations
of 3DSTE.
(3) 3DSTE-derived strain parameters of healthy
subjects were somewhat different from the
results of previous studies.10,11 It could be
explained by the fact that these parameters
depend on the place of measurement (basal
mid-superior regions etc.), even in healthy
subjects. Moreover, the values are affected
by the age, and other factors, as well.39
TABLE II
Clinical and Two-Dimensional Echocardiographic Characteris-
tics of Hypertrophic Cardiomyopathy Patients and Controls
HCM patients
(n = 23)
Controls
(n = 23)
Risk factors
Age (years) 48.5  15.1 41.0  11.8
Male gender (%) 14 (61) 13 (57)
Body mass index
(kg/m2)
27.4  5.0 25.3  3.5
Diabetes mellitus (%) 10 (44)* 0 (0)
Hypertension (%) 11 (48)* 0 (0)
Hypercholesterolemia
(%)
2 (9)* 0 (0)
Medications
b-blockers (%) 20 (87)* 0 (0)
ACE-inhibitors (%) 8 (35)* 0 (0)
Diuretics (%) 8 (35)* 0 (0)
Two-dimensional echocardiography
LA diameter (mm) 46.2  5.2† 33.8  3.9
LV end-diastolic
diameter (mm)
45.1  3.9 46.3  5.1
LV end-diastolic
volume (ml)
95.5  23.4 100.2  26.8
LV end-systolic
diameter (mm)
27.3  4.8* 31.2  4.9
LV end-systolic
volume (ml)
29.9  13.1 37.9  15.2
Interventricular
septum (mm)
22.8  5.6† 9.2  2.1
LV posterior
wall (mm)
12.1  4.2 10.6  2.2
LV ejection
fraction (%)
68.4  7.6 68.6  7.7
E/A 1.04  0.53 1.21  0.30
ACE = angiotensin-converting enzyme; LA = left atrial;
LV = left ventricular; HCM = hypertrophic cardiomyopathy.
*P = 0.02 versus Controls.
†P = 0.0001 versus Controls.
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(4) Despite the fact that LA appendage could
be analyzed by modern transthoracic
echocardiographic methodologies including
TDI,40,41 3DSTE34 etc., LA appendage
and pulmonary veins were excluded from
evaluations.
TABLE III
Comparison of 3DSTE-Derived Volumetric Left Atrial Parameters of Patients with Hypertrophic Cardiomyopathy and Controls
Controls
(n = 23)
HCM Patients
(n = 23)
HCM Patients with
Hypertension and/or
DM (n = 10)
HCM Patients
without
Hypertension and/
or DM (n = 13)
HCM Patients
with MR ≥2 (n = 9)
HCM Patients
with MR <2
(n = 14)
Calculated volumes
Vmax (mL) 36.0  6.1 66.4  20.4* 65.2  10.7* 67.2  26.0* 76.2  26.0*‡ 59.0  13.3*
Vmin (mL) 16.0  4.6 39.2  19.1* 38.9  14.1* 39.4  22.7* 46.6  23.8*‡ 32.7  13.3*
VpreA (mL) 24.0  6.2 53.6  19.9* 54.0  12.6* 53.3  24.5* 64.1  22.4*‡ 45.3  14.7*
Stroke volumes
TASV (mL) 20.0  4.6 27.2  9.7† 26.3  11.4† 27.8  8.5† 26.6  10.0† 26.3  9.5†
PASV (mL) 12.0  4.6 12.8  8.6 11.2  10.8 13.9  6.6 12.1  7.3 14.3  9.1
AASV (mL) 8.0  3.2 14.4  8.1† 15. 0  10.5† 13.9  6.0† 17.4  9.4† 12.6  6.8†
Emptying fractions
TAEF (%) 55.3  9.8 42.8  15.5† 40.8  16.9† 44.3  14.8† 41.1  14.9†‡ 45.6  15.6†
PAEF (%) 33.5  11.6 19.9  14.5† 16.8  16.1† 22.2  13.1† 15.7  9.3† 23.6  16.9†
AAEF (%) 33.3  9.5 28.6  14.3 27.8  17.6 29.3  11.9 29.4  17.3 29.0  12.5
Vmax = maximum left atrial volume; Vmin = minimum left atrial volume; VpreA = left atrial volume before atrial contraction;
TASV = total atrial stroke volume; TAEF = total atrial emptying fraction; AASV = active atrial stroke volume; AAEF = active atrial
emptying fraction; PASV = passive atrial stroke volume; PAEF = passive atrial emptying fraction; DM = diabetes mellitus;
HCM = hypertrophic cardiomyopathy; MR = mitral regurgitation; STE = speckle tracking echocardiography; 3D = three-dimen-
sional.
*P < 0.0001 versus controls.
†P < 0.05 versus controls.
‡P < 0.05 versus HCM patients with MR <2.
TABLE IV
Comparison of 3DSTE-Derived Left Atrial Strain Parameters of Patients with Hypertrophic Cardiomyopathy and Controls
Controls
(n = 23)
HCM
Patients
(n = 23)
HCM Patients
with Hypertension
and/or
DM (n = 10)
HCM Patients
without
Hypertension
and/or DM (n = 13)
HCM Patients
with MR ≥2
(n = 9)
HCM Patients
with MR <2
(n = 14)
Global strains
Radial strain (%) 19.6  11.7 12.2  6.7* 14.5  8.5 10.4  4.4* 12.1  5.8 12.3  7.4†
Circumferential
strain (%)
29.8  12.1 26.5  16.5 26.4  19.1 26.6  15.0 25.3  15.9 27.2  17.4
Longitudinal
strain (%)
23.9  6.3 18.0  7.4* 18.0  6.8† 18.0  8.1† 15.8  6.4* 19.4  7.9
3D strain (%) 12.5  10.2 6.1  4.4* 7.9  5.1 4.7  3.3* 6.6  4.8 5.8  4.2†
Area strain (%) 59.0  19.1 49.3  27.8 51.0  31.2 48.0  26.2 44.4  27.3 52.3  28.7
Mean segmental strains
Radial strain (%) 23.7  11.5 16.3  10.7† 18.6  8.6 14.6  3.2* 16.2  5.7 16.4  6.9†
Circumferential
strain (%)
38.6  23.5 29.9  18.2 31.3  17.9 28.8  15.1 26.8  17.1 31.9  15.6
Longitudinal
strain (%)
30.6  17.7 20.1  12.4† 20.5  6.1 19.7  7.9† 17.9  5.9† 21.4  7.6
3D strain (%) 17.0  9.5 10.7  8.3† 12.3  5.8 9.4  2.5* 11.0  4.3 10.5  4.6†
Area strain (%) 75.9  41.7 54.1  33.2† 56.4  32.2 52.4  26.3 49.4  29.5 57.1  28.3
DM = diabetes mellitus; HCM = hypertrophic cardiomyopathy; MR = mitral regurgitation; STE = speckle tracking echocardiogra-
phy; 3D = three-dimensional.
*P < 0.01 versus Controls.
†P < 0.05 versus Controls.
‡P < 0.05 versus HCM patients with MR <2.
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(5) There are several aspects of HCM including
genetic background, history of embolism,
development of arrhythmias, etc., their rela-
tionship with the LA dysfunction was not
examined in this study.
(6) The effects of dynamic obstructions on LA
functional parameters were not examined in
this study.
(7) LA function deteriorated in patients with sick
sinus syndrome and in those with paroxysmal
atrial ﬁbrillation.11 However, all of our
patients and controls were in sinus rhythm.
(8) This was a single-center experience and lim-
ited by a relatively small number of HCM
patients. Caution should be taken when
interpreting the results.
Conclusions:
Three-dimensional STE allows evaluation of LA
(dys) function by volumetric and strain analysis in
HCM. There is an opportunity of detailed assess-
ment of LA dysfunction in various forms of
structural and functional heart disease.
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